The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


RENE  RENEURON GROUP PLC  ORD 1P

RENEURON  Currency GBX 
Company




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 19-Apr-2013 RENE Presentation on Mechanisms of Action RNS +1.73% Up
16:40 17-Apr-2013 RENE Second Price Monitoring Extn RNS -5.29% Down
16:35 17-Apr-2013 RENE Price Monitoring Extension RNS -5.29% Down
16:40 04-Apr-2013 RENE Second Price Monitoring Extn RNS -2.87% Down
16:35 04-Apr-2013 RENE Price Monitoring Extension RNS -2.87% Down
07:02 28-Mar-2013 RENE Collaboration with Cell Therapy Catapult RNS -9.96% Down
07:00 27-Mar-2013 RENE Dosing Completed in Stroke Trial RNS -7.03% Down
07:00 26-Mar-2013 RENE Approvals for Stem Cell Trial in CLI RNS -4.32% Down
16:40 19-Mar-2013 RENE Second Price Monitoring Extn RNS +4.76% Up
16:35 19-Mar-2013 RENE Price Monitoring Extension RNS +4.76% Up
07:00 11-Mar-2013 RENE Wins Two Biomedical Catalyst Grants RNS +0.81% Up
16:35 06-Mar-2013 RENE Price Monitoring Extension RNS -4.80% Down
07:00 25-Feb-2013 RENE AIM Rule 17 Notification RNS +15.83% Up
07:00 29-Jan-2013 RENE Stroke Trial Update: Final Cohort Begins Dosing RNS -13.62% Down
16:40 11-Jan-2013 RENE Second Price Monitoring Extn RNS +21.68% Up
16:35 11-Jan-2013 RENE Price Monitoring Extension RNS +21.68% Up
07:01 04-Dec-2012 RENE ReNeuron to Present at UK Stroke Forum RNS -3.84% Down
07:00 04-Dec-2012 RENE Interim Results RNS -3.84% Down
07:00 22-Nov-2012 RENE Non-Clinical Data RNS +0.92% Up
07:00 21-Nov-2012 RENE Notification of Interim Results RNS +5.20% Up

 Page 1 of 2

| 1 | 2 | Next


RENEURON - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds